Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study.
暂无分享，去创建一个
Y. Oki | Shouhao Zhou | Xiaoyun Cheng | J. Westin | S. Neelapu | Jingjing Cao | Zhiqiang Wang | R. Davis | M. Fanale | F. Samaniego | L. Nastoupil | N. Fowler | F. Chu | M. Ma | L. Feng | Chizoba Obi | Lei Feng